MBX Biosciences, Inc. (NYSE:MBX) Receives $37.50 Consensus Price Target from Analysts
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have updated their coverage on […]
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have updated their coverage on […]
